What follow‑up questions should be asked for a female patient with ADHD and depression who is taking Wellbutrin XR (bupropion) 300 mg and Adderall XR (amphetamine/dextroamphetamine) 20 mg?

Follow-Up Questions for a Female Patient with ADHD and Depression on Wellbutrin XR 300 mg and Adderall XR 20 mg

The most critical follow-up question is whether the patient is pregnant, planning pregnancy, or breastfeeding, as this fundamentally changes medication management and monitoring priorities. 1

Reproductive Health Assessment

Pregnancy Status and Planning

• Ask directly about current pregnancy status – both medications require risk-benefit discussion if pregnancy is confirmed or planned 1
• Assess contraception use and pregnancy intentions – preconception counseling should occur before pregnancy, not after conception 1
• If planning pregnancy: Engage in shared decision-making about continuing stimulants versus intermittent use or switching to bupropion monotherapy, though bupropion is less efficacious for ADHD 1
• If currently pregnant: Monitor fetal growth, blood pressure, and maternal weight gain carefully; amphetamine derivatives show no demonstrated association with major congenital malformations 1, 2
• If breastfeeding: Discuss that bupropion can be maintained at therapeutic dose, but amphetamine derivatives require discussion of breastfeeding safety and consideration of timing feeds to minimize infant exposure 1

Medication Efficacy and Symptom Control

ADHD Symptom Response

• Quantify current ADHD symptom severity using standardized scales – ask specifically about attention, impulsivity, and hyperactivity in work, home, and social settings 3
• Assess functional impairment – ADHD treatment success is measured by daily functioning, not just symptom reduction 1
• Determine if current Adderall XR 20 mg dose provides adequate coverage throughout the day or if symptoms return before the next dose 4

Depression Symptom Response

• Screen for depressive symptom improvement – bupropion is indicated for depression but less effective than stimulants for ADHD 1, 5
• Assess for treatment-resistant depression features – if depression persists despite adequate bupropion dosing, the combination with amphetamine may provide synergistic benefit 6
• Monitor for mood instability or manic symptoms – bupropion can precipitate mania in undiagnosed bipolar disorder 7

Safety Monitoring

Cardiovascular Assessment

• Measure blood pressure and heart rate at every visit – both medications can increase these parameters 4, 7
• Ask about palpitations, chest pain, or syncope – stimulants are contraindicated in patients with heart disease or moderate-to-severe hypertension 4
• Screen for personal or family history of sudden cardiac death – this warrants cardiology evaluation before continuing stimulants 4

Neuropsychiatric Monitoring

• Screen for new or worsening anxiety, agitation, or panic attacks – these can emerge with both bupropion and stimulants 7
• Assess for suicidal ideation or behavior – bupropion carries a black box warning for increased suicidality risk 7
• Ask about psychotic symptoms (hallucinations, paranoia, delusions) – both medications can precipitate psychosis 4, 7
• Evaluate for bipolar disorder symptoms – irritability, decreased need for sleep, racing thoughts, or grandiosity suggest possible bipolar disorder that requires medication adjustment 7

Seizure Risk Assessment

• Ask about any seizure history or risk factors – bupropion has dose-related seizure risk (0.1% at 300 mg/day) and should be discontinued if seizure occurs 7
• Screen for eating disorders – bulimia and anorexia increase seizure risk with bupropion 7
• Review alcohol use – excessive alcohol or abrupt alcohol withdrawal increases seizure risk 7

Medication-Specific Concerns

Substance Use and Diversion Risk

• Assess for substance use history – Adderall XR is a Schedule II controlled substance with abuse potential 4
• Ask about medication storage and whether others have access – diversion is illegal and common with stimulants 4
• Screen for alcohol use – alcohol can increase dextroamphetamine plasma concentrations through presystemic effects 8

Drug Interactions

• Review all current medications, supplements, and over-the-counter drugs – both medications have significant interaction potential 4, 7
• Specifically ask about MAOIs – contraindicated with both medications (14-day washout required) 4, 7
• Ask about CYP2D6 inhibitors (e.g., fluoxetine, paroxetine, quinidine) – these can increase amphetamine levels, effectively increasing the dose 8
• Screen for other serotonergic medications – combining with bupropion may increase serotonin syndrome risk 7

Common Adverse Effects

• Ask about appetite and weight changes – both medications commonly cause decreased appetite and weight loss 4, 7
• Assess sleep quality and insomnia – stimulants frequently cause sleep disturbance; timing of Adderall XR dose matters 4
• Screen for dry mouth, headache, and gastrointestinal symptoms – common with both medications 4, 7
• Ask about sexual dysfunction – can occur with both medications 7

Comorbidity Screening

Anxiety Disorders

• Assess for co-occurring anxiety symptoms – ADHD frequently co-exists with anxiety disorders 1
• Determine if anxiety is primary or secondary to untreated ADHD – effective ADHD treatment often improves anxiety 2
• Note that stimulants are contraindicated if patient is "very anxious, tense, or agitated" per FDA labeling 4

Bipolar Disorder Screening

• Screen for lifetime history of manic or hypomanic episodes – treating unrecognized bipolar disorder with antidepressants alone increases risk of manic switch 7
• Ask about family history of bipolar disorder – increases patient risk 7
• If bipolar features present: Bupropion monotherapy is not recommended; mood stabilization must be achieved first 2

Functional Outcomes

Quality of Life Assessment

• Evaluate work or academic performance – functional improvement is the primary treatment goal 1, 3
• Assess interpersonal relationships and social functioning – ADHD significantly impacts these domains 3
• Screen for driving safety concerns – untreated ADHD increases accident risk 4

Non-Pharmacologic Treatment Integration

Psychotherapy Engagement

• Ask about current psychotherapy participation – cognitive behavioral therapy (CBT) is the most effective non-pharmacologic ADHD treatment 1, 2
• Consider dialectical behavior therapy (DBT) referral – shown to reduce ADHD symptoms and comorbid anxiety/depression 2
• Assess sleep hygiene and nutrition – these are critical for managing ADHD symptoms 1

Common Pitfalls to Avoid

• Do not assume depression is adequately treated if ADHD remains untreated – untreated ADHD prevents depression remission 2
• Do not add SSRIs for anxiety without first optimizing ADHD treatment – anxiety may be secondary to ADHD 2
• Do not discontinue medications abruptly if pregnancy is discovered – engage in risk-benefit discussion rather than reflexive cessation 1
• Do not overlook bipolar disorder screening – misdiagnosis leads to inappropriate treatment and worsening outcomes 7
• Do not ignore cardiovascular contraindications – stimulants can cause serious cardiac events in at-risk patients 4